# The roles of the small nucleolar RNA host gene family in ovarian cancer

## TL;DR

This paper reviews how a specific group of noncoding RNAs, called SNHGs, contribute to ovarian cancer development and treatment, aiming to provide new therapeutic insights.

## Contribution

The paper systematically reviews the roles and mechanisms of SNHGs in ovarian cancer for the first time.

## Key findings

- SNHGs are aberrantly expressed in ovarian cancer and are linked to poor prognosis.
- SNHGs influence ovarian cancer through multiple biological processes like proliferation and drug resistance.
- The paper explores SNHG roles in diagnosis and treatment, offering new therapeutic perspectives.

## Abstract

Ovarian cancer is one of the most malignant tumors in women. Long noncoding RNAs have been demonstrated to regulate multiple biological processes, including cell proliferation, migration, apoptosis, and drug resistance, in various cancers. Small nucleolar RNA (snoRNA) host genes (SNHGs) are a group of long noncoding RNAs. Studies have reported that SNHGs are aberrantly expressed in many kinds of cancers and are associated with poor patient prognosis. In ovarian cancer, SNHGs play critical roles in the development and progression of ovarian cancer via different pathways. However, there is a lack of systematic reports on the research progress of SNHGs in ovarian cancer. Therefore, we reviewed the studies on the roles of SNHGs in the early diagnosis, development, and treatment of ovarian cancer and explored the underlying mechanisms to provide new insights into the treatment of ovarian cancer.